Earningsreport

Q2/2024 3/31/2024 EPS -0.130 ZacksConsensus -0.130 ActVsEst 0.000 - In-Line

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data